Acute angle-closure glaucoma: Difference between revisions
Ostermayer (talk | contribs) |
|||
| (6 intermediate revisions by 5 users not shown) | |||
| Line 9: | Line 9: | ||
[[File:Acute angle closure glaucoma.jpg|thumb|Right eye with mid-sized, fixed pupil and ciliary flush.]] | [[File:Acute angle closure glaucoma.jpg|thumb|Right eye with mid-sized, fixed pupil and ciliary flush.]] | ||
*Abrupt onset of severe (usually [[Red Eye (Unilateral)|unilateral) eye pain]] | *Abrupt onset of severe (usually [[Red Eye (Unilateral)|unilateral) eye pain]] | ||
*Blurred vision | *[[Blurred vision]] | ||
*Halos around lights | *Halos around lights | ||
*Frontal or supraorbital [[headache]] | *Frontal or supraorbital [[headache]] | ||
*[[Nausea]] / [[vomiting]] / [[abdominal pain]] | *[[Nausea]] / [[vomiting]] / [[abdominal pain]] | ||
*Fixed, midposition pupil | |||
*Hazy cornea | |||
*Conjunctival injection most prominent at limbus (ciliary flush) | |||
*Rock-hard globe | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
| Line 18: | Line 22: | ||
==Evaluation== | ==Evaluation== | ||
* | *[[intraocular pressure|IOP]] >20 mm Hg | ||
*Slit lamp exam shows shallow anterior chamber and ''cell and flare'' | *Slit lamp exam shows shallow anterior chamber and ''cell and flare'' | ||
| Line 41: | Line 41: | ||
#Emergent ophthalmology consult | #Emergent ophthalmology consult | ||
#Recheck IOP at least hourly | #Recheck IOP at least hourly | ||
# | #Elevate head of bed to decrease IOP | ||
#Place patient in a well lit room (prevent pupillary dilation) | #Place patient in a well lit room (prevent pupillary dilation) | ||
#Start with a topical beta-blocker, α- | #Start with a topical beta-blocker, α-agonist and PO [[acetazolamide]] if no contraindications | ||
===Decrease production of aqueous humor=== | ===Decrease production of aqueous humor=== | ||
| Line 58: | Line 58: | ||
*1 drop in affected eye | *1 drop in affected eye | ||
=== | ===α2 agonist=== | ||
'''Brimonidine ophthalmic (alphagan) 0.2%''' OR '''Apraclonidine ophthalmic 1%''': | '''Brimonidine ophthalmic (alphagan) 0.2%''' OR '''Apraclonidine ophthalmic 1%''': | ||
*α agonist will increase trabecular outflow | *α agonist will increase trabecular outflow | ||
| Line 72: | Line 72: | ||
===Reduce volume of aqueous humor=== | ===Reduce volume of aqueous humor=== | ||
These therapies are usually resolved for failure of other treatments. Hyper osmotic agents such as mannitol are effective but are contraindicated in renal failure and can cause hypotension in the volume depleted patient. | These therapies are usually resolved for failure of other treatments. Hyper osmotic agents such as mannitol are effective but are contraindicated in renal failure and can cause hypotension in the volume depleted patient. | ||
*'''[[Mannitol]]''': 1-2 g/kg IV (most common) | *'''[[Mannitol]]''': 1-2 g/kg IV given over 45 minutes to minimize cerebral effecfts (most common) | ||
*'''50% glycerin (Osmoglyn)''' OR '''45% isosorbide (Ismotic)''': 1.5 mL/kg PO (rarely used) | *'''50% glycerin (Osmoglyn)''' OR '''45% isosorbide (Ismotic)''': 1.5 mL/kg PO (rarely used) | ||
===[[ | ===[[Steroids]]=== | ||
Topical steroids not indicated during acute attack, but may help inflammation after IOP under control. | *Topical steroids not indicated during acute attack, but may help inflammation after IOP under control. | ||
**[[prednisolone]] acetate 1% 1 gtt every 15 to 30 minutes four times, then q1h <ref>Guluma, K., & Lee, J. E. (2018). Ophthalmology. In Rosen's Emergency Medicine: Concepts and Clinical Practice (9th ed.). Philadephia, PA: Elsevier/Saunders.</ref> | |||
==Disposition== | |||
==See Also== | ==See Also== | ||
Revision as of 21:27, 5 July 2020
Background
Pathophysiology
- Obstructed aqueous outflow tract → aqueous humor builds up → increased intraocular pressure (IOP) → optic nerve damage → vision loss
- Increased posterior chamber pressure causes iris to bulge forward (iris bombé) → further obstruction of outflow tract → further increase IOP
- Acute attack is usually precipitated by pupillary dilation
Clinical Features
- Abrupt onset of severe (usually unilateral) eye pain
- Blurred vision
- Halos around lights
- Frontal or supraorbital headache
- Nausea / vomiting / abdominal pain
- Fixed, midposition pupil
- Hazy cornea
- Conjunctival injection most prominent at limbus (ciliary flush)
- Rock-hard globe
Differential Diagnosis
Unilateral red eye
- Nontraumatic
- Acute angle-closure glaucoma^
- Anterior uveitis
- Conjunctivitis
- Corneal erosion
- Corneal ulcer^
- Endophthalmitis^
- Episcleritis
- Herpes zoster ophthalmicus
- Inflamed pinguecula
- Inflamed pterygium
- Keratoconjunctivitis
- Keratoconus
- Nontraumatic iritis
- Scleritis^
- Subconjunctival hemorrhage
- Orbital trauma
- Caustic keratoconjunctivitis^^
- Corneal abrasion, Corneal laceration
- Conjunctival hemorrhage
- Conjunctival laceration
- Globe rupture^
- Hemorrhagic chemosis
- Lens dislocation
- Ocular foreign body
- Posterior vitreous detachment
- Retinal detachment
- Retrobulbar hemorrhage
- Traumatic hyphema
- Traumatic iritis
- Traumatic mydriasis
- Traumatic optic neuropathy
- Vitreous detachment
- Vitreous hemorrhage
- Ultraviolet keratitis
^Emergent diagnoses ^^Critical diagnoses
Evaluation
- IOP >20 mm Hg
- Slit lamp exam shows shallow anterior chamber and cell and flare
Definition: 3 signs + 2 symptoms
- At least 3 of these signs:
- IOP >21 mm Hg
- Conjunctival injection
- Corneal epithelial edema
- Mid-dilated nonreactive pupil
- Shallow anterior chamber with occlusion
- At least 2 of these symptoms:
- Ocular pain
- Nausea/vomiting
- History of intermittent blurring of vision with halos
Management
Goal of medical therapy is to 'break the attack' in order to prepare the patient for laser iridotomy.[1]
- Emergent ophthalmology consult
- Recheck IOP at least hourly
- Elevate head of bed to decrease IOP
- Place patient in a well lit room (prevent pupillary dilation)
- Start with a topical beta-blocker, α-agonist and PO acetazolamide if no contraindications
Decrease production of aqueous humor
Timolol 0.5%:
- Blocks beta receptors on ciliary epithelium
- 1 drop in affected eye, repeat in 1 hour if needed.
- Blocks productions of HCO3-, which draws Na+ into the eye; water follows by osmosis to form aqueous humour
- 500mg IV or PO (PO preferred unless patient is nauseated)
- Can substitute methazolamide 100mg if patient has renal failure.
- Contraindicated in sickle cell patients
Dorzolamide (Trusopt) 2%:
- topical carbonic anhydrase inhibitor
- 1 drop in affected eye
α2 agonist
Brimonidine ophthalmic (alphagan) 0.2% OR Apraclonidine ophthalmic 1%:
- α agonist will increase trabecular outflow
- 1 drop in affected eye
Facilitate outflow of aqueous humor
Pilocarpine 1%–2%:
- Parasympatholytic alkaloid acts on muscarinic receptors found on iris sphincter muscle → causes muscle to contract → miosis → pulls iris away from trabecular network
- 1 drop in affected eye every 15 minutes x 2-4 doses, then every 4 to 6 hours
- Likely does not work until IOP drops below 40-50 mmHg, but still give immediately upon diagnosis
- Note: may make fundoscopic evaluation more difficult for ophtho consultant due to miosis
Reduce volume of aqueous humor
These therapies are usually resolved for failure of other treatments. Hyper osmotic agents such as mannitol are effective but are contraindicated in renal failure and can cause hypotension in the volume depleted patient.
- Mannitol: 1-2 g/kg IV given over 45 minutes to minimize cerebral effecfts (most common)
- 50% glycerin (Osmoglyn) OR 45% isosorbide (Ismotic): 1.5 mL/kg PO (rarely used)
Steroids
- Topical steroids not indicated during acute attack, but may help inflammation after IOP under control.
- prednisolone acetate 1% 1 gtt every 15 to 30 minutes four times, then q1h [2]
Disposition
See Also
References
- ↑ Primary Angle Closure Preferred Practice Pattern Guideline. American Academy of Ophthalmology. Angle Closure PPP Accessed 06/17/15.
- ↑ Guluma, K., & Lee, J. E. (2018). Ophthalmology. In Rosen's Emergency Medicine: Concepts and Clinical Practice (9th ed.). Philadephia, PA: Elsevier/Saunders.